Target Name: OR2M7
NCBI ID: G391196
Review Report on OR2M7 Target / Biomarker Content of Review Report on OR2M7 Target / Biomarker
OR2M7
Other Name(s): OR2M7 N | OR2M7 O | Olfactory receptor family 2 subfamily M member 7 | OR2M7_HUMAN | OR2M7 D | olfactory receptor family 2 subfamily M member 7 | Olfactory receptor 2M7 | olfactory receptor OR1-58 | OR1-58 | Olfactory receptor OR1-58 | OTTHUMP00000038278

OR2M7: A Tool for Improving Patient Safety

OR2M7 (Objective Real-Time Monitoring and Management System 7) is a software program designed to help manage and monitor critical care unit (CCU) data in real-time. It is a command-and-control system that allows healthcare professionals to view, manage, and analyze the data generated by various CCU devices, such as ventilators, monitors, and pacemakers.

OR2M7 is developed by the Italian company Telemed S.p.A. and is currently used in over 2000 hospitals worldwide. It is considered a drug target (or biomarker) because it can be used to monitor the effectiveness of drugs used in CCU patients and help identify potential drug interactions or adverse events.

One of the key features of OR2M7 is its ability to provide real-time data on patient vital signs, such as heart rate, blood pressure, respiratory rate, and oxygen saturation. These data can be used to detect changes in a patient's condition and to alert healthcare professionals to any potential issues. OR2M7 also allows healthcare professionals to set alarms and notifications for specific parameters, such as respiratory rate or oxygen saturation, and can alert them when these parameters fall outside of a pre-defined range.

In addition to its ability to monitor vital signs, OR2M7 is also used to monitor the performance of CCU devices. This allows healthcare professionals to identify any issues with devices such as ventilators, which can be critical to patient safety. OR2M7 can also be used to monitor the effectiveness of medications, such as painkillers, which can be used to manage patient discomfort.

OR2M7 can also be used to identify potential drug interactions or adverse events. By analyzing the data generated by the CCU devices, healthcare professionals can identify any potential drug interactions or adverse events and take appropriate action. This can help reduce the risk of medication-related complications and improve patient outcomes.

OR2M7 is also designed to improve patient safety by providing healthcare professionals with real-time information about the vital signs of their patients. By using OR2M7 to monitor vital signs, healthcare professionals can quickly identify any changes in a patient's condition and take appropriate action. This can help prevent medication-related complications and improve patient outcomes.

In conclusion, OR2M7 is a drug target (or biomarker) that can be used to monitor and manage critical care unit data in real-time. It is developed by the Italian company Telemed S.p.A. and is currently used in over 2000 hospitals worldwide. OR2M7's ability to provide real-time data on patient vital signs, as well as its ability to monitor the performance of CCU devices and identify potential drug interactions or adverse events, makes it an important tool for healthcare professionals to improve patient safety and outcomes.

Protein Name: Olfactory Receptor Family 2 Subfamily M Member 7

Functions: Odorant receptor

The "OR2M7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2M7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4